FDA Clears New Blood Test that Could Speed Alzheimer’s Diagnosis and Treatment

Health & LifestyleNews
124

Listen to article (english)

Translate to Spanish or other 102 languages!

With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes
With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed. Image for illustration purposes

Mega Doctor News

- Advertisement -

By George Washington University

Newswise – With Alzheimer’s rates climbing and diagnoses often delayed until symptoms progress, a new FDA-cleared blood test could mark a turning point in how the disease is identified and managed.

This week, the FDA cleared Roche’s Elecsys pTau181 test — only the second blood-based biomarker test approved this year for Alzheimer’s disease. The test, developed with Eli Lilly, gives primary care physicians a faster way to help rule out Alzheimer’s in patients showing signs of cognitive decline, potentially reducing reliance on costly PET scans and getting patients to answers — and treatment — sooner.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
HHSC Encourages Preventive Care During Breast Cancer Awareness Month
Next article
STHS Children’s Partners with Spirit Halloween for Pre-Halloween Party for Patients

More Articles

5 Ways to Protect Your Family from Allergy and Asthma Triggers This 4th of July

The Fourth of July is about fireworks, barbecues and spending time with family and friends. But if you or your child has allergies or asthma, holiday activities can sometimes bring unexpected triggers. Fortunately, a few simple precautions can help you enjoy the festivities while keeping symptoms under control.

Patients Increasingly Use Chatbots as Therapists, Psychologists Report

More than three-quarters of psychologists report their patients are discussing artificial intelligence (AI) in therapy, according to a survey by the American Psychological Association.

Moles, Spots, and Changes: How to Tell If It’s Skin Cancer

Texas Border Business Normal Moles – Normal moles are usually one color: brown,...

STHS Edinburg Teams Up with Reserva Coffee Roasters for Premium Patient Experience

With the grand opening of Reserva Coffee Roasters’ newest café, the warmth and comfort of home are now just a brew away at South Texas Health System Edinburg (STHS) and STHS Children’s, helping create the perfect setting for connection, conversation and community for hospital visitors, staff and physicians.
- Advertisement -